REQUEST A DEMO
Total
USD $0.00
Search more companies

Mb Pharma S.R.O. (Czech Republic)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Mb Pharma S.R.O. Profile Updated: November 17, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Mb Pharma S.R.O. is a company in Czech Republic, with a head office in Prague. The company operates in the Pharmaceutical Preparation Manufacturing industry. It was first established on August 12, 1998. 25 - 49 (2024) employees currently work for Mb Pharma S.R.O.. The company’s latest financial report indicates a net sales revenue drop of 26.46% in 2023. Its’ total assets recorded a negative growth of 6.02%. The net profit margin of Mb Pharma S.R.O. decreased by 1.79% in 2023.

Headquarters
Rubesova 72/9
Prague; The City of Prague; Postal Code: 12000

Contact Details: Purchase the Mb Pharma S.R.O. report to view the information.

Basic Information
Total Employees:
Purchase the Mb Pharma S.R.O. report to view the information.
Outstanding Shares:
Purchase the Mb Pharma S.R.O. report to view the information.
Registered Capital:
Purchase the Mb Pharma S.R.O. report to view the information.
Incorporation Date:
August 12, 1998
Key Executives
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Mb Pharma S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CZK. Absolute financial data is included in the purchased report.
Net sales revenue
-26.46%
Total operating revenue
-28.95%
Operating profit (EBIT)
-65.63%
EBITDA
N/A
Net Profit (Loss) for the Period
-97.56%
Total assets
-6.02%
Total equity
0.06%
Operating Profit Margin (ROS)
-2.7%
Net Profit Margin
-1.79%
Return on Equity (ROE)
-2.46%
Debt to Equity Ratio
8.47%
Quick Ratio
0.71%
Cash Ratio
0.1%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?